Theobromine (Xanthine Alkaloid · Vasodilatory · Bronchodilatory · Sustained Energy)
| Compound | Theobromine |
| Chemical class | Alkaloid — Purine (Xanthine; 3,7-Dimethylxanthine) |
| CAS | 83-67-0 |
| Primary source | Theobroma cacao (cocoa beans, chocolate) |
| Key applications | Vasodilatory, bronchodilatory, mood enhancement, sustained energy |
| Claim strength | Moderate |
| Typical form | Cocoa extract standardised to theobromine; theobromine isolate |
| Buy from Herbuno |
Commercial source: Theobromine is commercially available as a constituent of cocoa (Theobroma cacao) polyphenol extract (10–12% total polyphenols), and as an isolated compound from cocoa bean processing. See sourcing options below. Traditional use: Cacao has been consumed as a beverage and ceremonial food by Mesoamerican civilisations (Maya, Aztec) for at least 3,000 years, with the original bitter cacao preparations recognised for their energising and mood-enhancing properties. Theobromine is the primary alkaloid in cacao responsible for its sustained mild stimulant effects, distinct from caffeine’s more rapid and intense action. Research trajectory: Theobromine has attracted research for its unique pharmacological profile — mild CNS stimulation, vasodilation, bronchodilation, and a longer duration of action than caffeine — making it relevant for sustained energy, cardiovascular health, and respiratory applications. See sourcing options below.
Evidence for Theobromine Applications
Vasodilation and cardiovascular: Theobromine dilates blood vessels via phosphodiesterase inhibition (increasing cAMP) and direct vascular smooth muscle relaxation. Human studies with theobromine or dark chocolate (theobromine-rich) show improvements in endothelial function (FMD), reductions in blood pressure, and reduced LDL oxidation. Cocoa flavanol RCTs (CocoaVia programme) provide the most robust cardiovascular evidence for cocoa preparations. Claim strength: Moderate.
Bronchodilation: Theobromine is a mild bronchodilator via phosphodiesterase inhibition in bronchial smooth muscle, comparable in mechanism (but lower in potency) to theophylline (the pharmaceutical xanthine bronchodilator). Human studies show theobromine reduces chronic cough via sensory nerve inhibition — a distinct antitussive mechanism from opioid cough suppressants. Claim strength: Moderate.
Mood enhancement and sustained energy: Theobromine’s longer half-life (~7 hours vs caffeine’s 3–5 hours) produces sustained mild CNS stimulation without caffeine’s more abrupt peak and crash. Combination with caffeine (naturally co-present in chocolate) provides complementary fast-acting (caffeine) and sustained (theobromine) energy profiles. Human studies on mood after dark chocolate consumption show consistent positive mood effects partly attributed to theobromine. Claim strength: Moderate.
Browse Standardised Extract Powders →
Dosage & Formulator Specification
Human clinical dose: 250–1000 mg/day theobromine for cardiovascular and bronchodilatory applications. Dark chocolate studies use 40–100 g/day dark chocolate, delivering approximately 200–500 mg theobromine. For supplement formulations, theobromine at 200–500 mg per serving is appropriate for cardiovascular and sustained energy applications. Herbuno’s Cocoa Polyphenol Extract (10–12% total polyphenols) delivers theobromine alongside epicatechin and procyanidins.
Theobromine is notable for its much greater safety in humans than in dogs and cats — dogs metabolise theobromine slowly (12–18 hour half-life), making chocolate genuinely toxic to dogs. Human theobromine metabolism is approximately 6–10-fold faster. At supplement doses, human theobromine adverse effects are minimal; the NOAEL is well above supplement-level doses. Isolated theobromine powder is commercially available from cocoa processing by-products.
Frequently Asked Questions — Theobromine
How does theobromine differ from caffeine pharmacologically?
Both are xanthine methylated derivatives acting via phosphodiesterase inhibition and adenosine receptor antagonism. Key differences: theobromine (3,7-dimethylxanthine) has lower CNS stimulant potency but stronger vasodilatory and bronchodilatory effects than caffeine (1,3,7-trimethylxanthine); theobromine has a longer half-life (~7 hours vs ~4 hours for caffeine); theobromine has lower adenosine A2A receptor affinity (less alertness effect) but stronger PDE inhibition in vascular smooth muscle. The practical result: caffeine for acute alertness; theobromine for sustained gentle energy with cardiovascular benefit.
Is theobromine the reason dark chocolate improves mood?
Partly. Theobromine contributes to chocolate’s mood effects through mild CNS stimulation and vasodilation improving cerebral blood flow. Other contributors include: phenylethylamine (trace amounts, rapidly metabolised), anandamide analogues (minor), epicatechin (endothelial function, cerebral blood flow), magnesium, and the hedonic experience of chocolate itself. Isolating theobromine’s contribution from the full chocolate matrix in human mood studies is methodologically challenging.
Can theobromine be used as a natural cough suppressant?
Yes — there is genuine clinical evidence for theobromine’s antitussive properties. A human RCT demonstrated theobromine (1000 mg) is significantly more effective than codeine for persistent cough via sensory nerve desensitisation (TRPA1 and TRPV1 channel inhibition on afferent sensory nerves). This mechanism is distinct from opioid cough suppressants and potentially superior for dry or irritant cough. The antitussive application is a clinically differentiated positioning for theobromine that is not widely exploited in supplement markets.
Why is chocolate toxic to dogs but safe for humans?
Dogs have a much slower theobromine metabolism (hepatic methylxanthine degradation rate is ~12–18-fold slower in dogs than humans), leading to toxic plasma accumulation from quantities that are trivial for humans. At 100–200 mg/kg, theobromine causes cardiac arrhythmias, seizures, and death in dogs. Human toxicity would require orders-of-magnitude higher doses. This species-specific pharmacokinetic difference, not a difference in receptor sensitivity, explains chocolate’s toxicity to dogs.
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery